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Sarcoplasmic reticular  Ca2+‑ATPase 
inhibition paradoxically 
upregulates murine skeletal muscle 
 Nav1.4 function
Sean X. Liu1, Hugh R. Matthews1 & Christopher L.‑H. Huang 1,2*
Skeletal muscle  Na+ channels possess  Ca2+‑ and calmodulin‑binding sites implicated in Nav1.4 current 
(INa) downregulation following ryanodine receptor (RyR1) activation produced by exchange protein 
directly activated by cyclic AMP or caffeine challenge, effects abrogated by the RyR1‑antagonist 
dantrolene which itself increased INa. These findings were attributed to actions of consequently altered 
cytosolic  Ca2+,  [Ca2+]i, on  Nav1.4. We extend the latter hypothesis employing cyclopiazonic acid (CPA) 
challenge, which similarly increases  [Ca2+]i, but through contrastingly inhibiting sarcoplasmic reticular 
(SR)  Ca2+‑ATPase. Loose patch clamping determined  Na+ current (INa) families in intact native murine 
gastrocnemius skeletal myocytes, minimising artefactual  [Ca2+]i perturbations. A bespoke flow system 
permitted continuous INa comparisons through graded depolarizing steps in identical stable membrane 
patches before and following solution change. In contrast to the previous studies modifying RyR1 
activity, and imposing control solution changes, CPA (0.1 and 1 µM) produced persistent increases 
in INa within 1–4 min of introduction. CPA pre‑treatment additionally abrogated previously reported 
reductions in INa produced by 0.5 mM caffeine. Plots of peak current against voltage excursion 
demonstrated that 1 µM CPA increased maximum INa by ~ 30%. It only slightly decreased half‑maximal 
activating voltages (V0.5) and steepness factors (k), by 2 mV and 0.7, in contrast to the V0.5 and k shifts 
reported with direct RyR1 modification. These paradoxical findings complement previously reported 
downregulatory effects on Nav1.4 of RyR1‑agonist mediated increases in bulk cytosolic  [Ca2+]. They 
implicate possible local tubule‑sarcoplasmic triadic domains containing reduced  [Ca2+]TSR in the 
observed upregulation of Nav1.4 function following CPA‑induced SR  Ca2+ depletion.
The skeletal muscle  Na+ channel  Nav1.4 structure possesses several potential  Ca2+ and calmodulin (CaM) bind-
ing or modulation sites. These may permit (a)  Ca2+ binding to one or more C-terminal EF-like hand  motifs1, (b) 
CaM binding to a C-terminal isoleucine-glutamine (IQ) domain following  Ca2+ binding to EF-hand motifs on 
the CaM  itself2,3, and (c)  Ca2+/CaM-binding to a III–IV loop  site4. It also possesses (d) sites phosphorylatable by 
CaM kinase II (CaMKII) itself regulated by  Ca2+/CaM5 and (e) a phosphorylation site for phosphokinase  C6. One 
or more of these sites may underly in vitro single-cell patch-clamp reports that elevating  [Ca2+]i to ~ 2 µM through 
rapid photo-release and  Ca2+ overspill from neighbouring  Ca2+ channels reduced peak  Na+ current densities, INa, 
in  Nav1.4-transfected HEK293 cells and skeletal muscle cell lines, effects abrogated by intracellular  BAPTA7. These 
effects were abolished with mutations in either the  Ca2+-binding-EF hands on CaM or the  Nav1.4 C-terminal IQ 
domain, implicating CaM binding to the IQ domain in the  [Ca2+]i-mediated  Nav1.4  modulation2,7,8.
These findings were extended to native intact working murine skeletal myocytes using loose patch clamp 
methods that avoided further artefactual intracellular  Ca2+ perturbations arising from the intrapipette EGTA used 
in conventional patch clamping. Ryanodine receptor (RyR1) agonists known to gate sarcoplasmic reticular (SR) 
store  Ca2+ release reversibly downregulated INa. These effects of both the Epac activator 8-(4-chlorophenylthio)
adenosine 3′,5′-cyclic monophosphate (8-CPT) and RyR1 agonist caffeine were abrogated by the RyR1 antagonist 
 dantrolene9,10. Dantrolene itself contrastingly produced increases in INa. Murine cardiac muscle showed concord-
ant effects of enhanced SR  Ca2+ release either with 8-CPT  application11 or in RyR2-P2328S genetic  variants12.
The present experiments test and extend the resulting hypothesis implicating alterations in  [Ca2+]i in 
such a feedback modification of  Nav1.4 function suggested by the latter reports. They now explore effects of 
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cyclopiazonic acid (CPA) challenge. In common with  caffeine13 this increases bulk cytosolic  [Ca2+]i14. However, 
rather than enhancing RyR-mediated  Ca2+ release, it does so through inhibiting SR  Ca2+-ATPase (SERCA). This 
reduces SR cytosolic  Ca2+ uptake thereby depleting SR store  Ca2+15. The experiments similarly employed loose 
patch clamping protocols, but these were further modified to permit pair-wise statistical comparisons of INa in 
the same established undisrupted patch before and following solution changes delivering the pharmacological 
challenge. This dealt with any between-patch INa variations reflecting previously reported non-uniform ion 
channel, including Nav1.4, distributions over the muscle fibre  surface16.
We here report that in contrast to expectations from the previous experiments that modified RyR1-mediated 
 Ca2+  release9,10, CPA paradoxically enhanced rather than reduced INa. We reconcile these findings with those 
previous reports, in terms of a scheme in which at least some tubular (T) Nav1.4 are exposed to local T-SR triad 
 Ca2+ concentrations  [Ca2+]TSR themselves influenced by terminal cisternal RyR1-mediated fluxes of SR  Ca2+. The 
latter would be increased by the RyR1 agonists, caffeine and 8-CPT, but decreased by SR  Ca2+ depletion produced 
by the SERCA inhibitor CPA. Such tubular Nav1.4 likely make a substantial contribution to measured INa17,18, 
given that T-tubules comprise up to 80% of muscle fibre membrane surface  area19.
Results
Inward loose patch currents obtained in response to depolarizing voltage steps. INa currents 
elicited by the pulse protocol, normalized to patch areas giving current densities, initially rapidly increased to 
attain peak values before showing inactivation decays. This fulfilled expectations from previous studies simi-
larly exploring INa using the loose patch clamp  technique9,10,16. The peak currents obtained through the range 
of applied voltage steps were then quantified in current–voltage (I–V) relationships. Figure 1a demonstrates 
that these relationships assumed a similar form, but the current magnitudes varied between individual patches. 
Thus, whilst being normally distributed (Shapiro–Wilkes test, P = 0.13), the maximum peak currents (mean 
− 16.45 pA/µm2) showed significant variation (SD = 9.605, SEM = 2.329 pA/µm2; n = 17), confirming previous 
 reports16. Nevertheless, the experimental design separated such between-patch variability from the observed 
changes associated with the pharmacological challenge under investigation.
Figure 1.  Current–voltage (I–V) relationships between patches. Data from (a) individual patches showing 
between-patch, normally distributed (n = 17; Shapiro–Wilkes test, P = 0.13), variations in peak currents obtained 
through the explored range of applied voltage steps, with (b) their means and standard errors.
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Control solution change protocols conserve patch and inward current characteristics. To fulfil 
the latter strategy, the experiments studied ionic currents before and following the solution changes introducing 
either control solution or solutions containing the test agents, making recordings before and following each solu-
tion change, from the same established patch. This permitted the pairwise comparisons of control and test results 
adopted here. This required maintenance of stable patches before and following the solution changes involving 
challenge with extracellularly applied cyclopiazonic acid (CPA) or otherwise. The externally applied CPA used 
here targeted cytosolic SERCA-mediated  Ca2+ re-uptake into the SR, in contrast with the RyR1-specific agonist 
and antagonist agents employed in the previous studies. The CPA was used at 0.1/1.0 µM concentrations, well in 
excess of the reported 10–20 nM half-maximal concentration, to achieve maximal SERCA  inhibition15. When 
recording from small cells, it is possible to effect rapid solution changes by stepping the interface between paral-
lel continuous perfusing  streams20. However this approach was not feasible in this case owing to the size of the 
tissue, so the entire bath solution was exchanged. The configuration used here nevertheless permitted relatively 
rapid solution changes by simultaneous removal of the initial whilst adding the new test solution, thereby main-
taining bath solution level constant. This prevented vertical forces at the patch site due to changes in buoyancy 
forces acting on the muscle. This was despite reduction of the bath volume using the obturator insert to ensure 
completeness of the solution change.
Control experiments in which the solution changes re-introduced Krebs–Henseleit (K–H) solutions contain-
ing no CPA were performed to test the effectiveness and validity of this approach. These manoeuvres produced 
little change in patch seal resistances, which suggested the solution changes did not disrupt patch integrity. Cur-
rents obtained from the subsequent patch recordings before (Fig. 2a) and following the solution changes (Fig. 2b) 
were similar in form and magnitude, remaining so with the later recordings (Fig. 2c). Furthermore, currents 
obtained through protocols in which test voltage steps had amplitudes in increasing order closely matched those 
in which the test voltage steps were applied with amplitudes in decreasing order. This confirmed that patch and 
current characteristics were stable throughout the voltage clamp step protocol. They also yielded similar derived 
current voltage (I–V) relationships, with a stability confirmed in comparisons of results obtained before, and 
1 min and 4 min following the solution change (Fig. 2d).
Figure 2.  Currents and current–voltage (I–V) relationships through control solution changes. (a–c) Families 
of current traces obtained from a patch in response to voltage clamp steps applied relative to resting membrane 
potential (RMP), (a) before, (b) 1 min and (c) 4 min after solution change to K–H with identical composition 
to the original bath solution. Each trace shown is the average of two recordings obtained from the set of pulse 
protocols. It is displaced horizontally and vertically from the previous trace. Currents are shown over the cycle 
time range of 53–62 ms within the pulse protocol in which the voltage step was delivered at 55 ms. (d) Plots 
of peak current density against test pulse voltage excursion, comparing current–voltage (I–V) relationships 
between the same axes, illustrating a < 12% alteration in maximum peak current following the solution change.
4
Vol:.(1234567890)
Scientific Reports |         (2021) 11:2846  | https://doi.org/10.1038/s41598-021-82493-w
www.nature.com/scientificreports/
Cyclopiazonic acid (CPA) challenge upregulates  Na+ current. In the initial experiments testing the 
effects of the SERCA inhibitor CPA on the measured currents, the solution exchanger was first loaded with 50 ml 
of K–H solution containing 0.1 µM CPA and connected to the preparation. This concentration was previously 
reported to cause significant effects in Langendorff-perfused murine  hearts21. Following establishment of the 
patch seal, a set of recordings using a bath solution containing no drug were then obtained. The solution change 
was then promptly performed. Further recordings of ionic current were then made in the presence of CPA start-
ing at 1 min post-exposure.
Figure 3 exemplifies ion current families obtained immediately before (a) and 1 min following (b) such a 
manoeuvre. Patch seal resistances remained stable through the solution change. In the presence of CPA, the peak 
current magnitudes were increased at all activating voltages by 1 min after the solution change. When obtaining 
the families of records, the currents were comparable through the pulse sequences applied using step amplitudes 
in increasing or in decreasing order. The current voltage (I–V) relationships showed increased inward current 
magnitudes but otherwise were similar in form. These effects stably persisted at 4 min following the solution 
change. However, alterations in patch characteristics, particularly the seal resistances, over longer, ~ 16 min, 
times prompted corroborative studies at higher, 1 µM CPA, concentrations than the 0.1 and 0.15 µM levels used 
previously in murine  preparations21 as these might produce effects at earlier times. These employed less closely 
graded voltage clamp steps encompassing a smaller range of depolarizations. This permitted recordings to be 
completed in < 60 s whilst still permitting characterization of the current–voltage relationships derived below.
These studies demonstrated similar findings at the CPA concentrations (1 µM) expected to supramaximally 
inhibit SERCA. They then gave more consistent, greater, increases in the currents observed at 1 min than did 
0.1 µM CPA (Fig. 4a,b). Similarly altered current deflections were observed at the longer 4 min intervals (Fig. 4c). 
Furthermore, in all cases the initially observed current features at each voltage returned with the subsequently 
imposed voltage steps of decreasing amplitude. Current–voltage relationships obtained in the presence of 1 µM 
CPA resembled the relationships observed at the lower 0.1 µM concentration (Fig. 4d). These findings together 
implicate CPA in increasing the observed inward currents observed on loose patch clamping.
CPA pretreatment abrogates effects of caffeine on  INa. The present experiments using the SERCA 
inhibitor CPA, expected to deplete sarcoplasmic reticular (SR)  Ca2+ stores, complemented previous experiments 
stimulating SR  Ca2+ store release using the RyR1 agonist caffeine. Both agents were reported to increase bulk 
cytosolic  [Ca2+]i13,14. However, in contrast to the sustained CPA action in increasing INa reported here, caffeine 
challenge caused decreases in INa. But the latter effects were transient, reflecting its successive, RyR1-mediated, 
Figure 3.  Effects of 0.1 µM CPA on currents and related I–V relationships. (a–c) Families of current traces 
obtained from applications of depolarizing voltage steps to a patch (a) before, (b) 1 min and (c) 4 min after 
solution change to K–H containing 0.1 µM CPA. (d) The resulting peak currents are plotted against test 
voltage excursions to give current voltage (I–V) relationships as in Fig. 2, here illustrating a ~ 20% alteration in 
maximum peak current following the solution change.
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activation followed by inactivation of SR  Ca2+  release10. Accordingly, further control experiments challenged 
CPA-treated muscle preparations with a superimposed addition of 0.5 mM caffeine (Fig. 5).
After setting up a preparation in K–H solution with no drug, the solution exchanger introduced 1 µM CPA. 
Patches were then obtained and a family of  Na+ currents were recorded. Prior to this, the solution exchanger was 
loaded in readiness with 50 ml of K–H solution containing 1 µM CPA in combination with 0.5 mM caffeine. This 
permitted the prompt second solution change which thereby additionally introduced caffeine after ~ 10 min of 
pre-incubation in CPA. Further recordings were then taken from the same patch at 1 and 4 min as before. This 
challenge with multiple agents targeting  Ca2+ homeostasis did not affect patch seal resistances, and recordings 
of families of  Na+ currents remained possible. Furthermore, the findings contrasted with the previous reports 
in which 0.5 mM caffeine alone markedly decreased  Na+ currents. Thus, this additional pre-exposure to CPA if 
anything, slightly increased the  Na+ currents, a change in the opposite direction as that reported when caffeine 
challenge was applied following SR  Ca2+  depletion10.
Statistical quantification of current–voltage relationships. Figure 6 summarizes the current–volt-
age relationships shown by the peak  Na+ currents and their further analysis. It compares findings obtained 
prior to solution change with those obtained 1 min following alterations to solutions containing 0.0 µM (a, d; 
control), 0.1 µM (b, e) and 1 µM CPA (c, f) respectively. The resulting pairs of current–voltage (I–V) relation-
ships remained consistent in shape, suggesting comparable activation characteristics. The left plots (a–c) show 
unpaired data showing peak currents from different patches plotted as means and standard errors of the mean 
(SEM) representing between-patch variations from the replicate experiments in the groups above. The right 
plots (d–f) illustrate the corresponding data normalized to the corresponding maximum peak current for each 
individual patch prior to CPA challenge and their SEMs. This analysis separates the between-patch variations in 
peak currents illustrated in Fig. 1 and reported on previous  occasions16 from the paired within-patch alterations 
in  Na+ current resulting from CPA challenge under examination.
As in previous reports, their rising phases for each patch were described by fitting them to a two-state 
Boltzmann function. Data within a range of voltages from − 40 mV relative to RMP to voltage excursions that 
produced the greatest magnitude of peak current (typically + 70 mV to + 90 mV relative to RMP) were fitted 
using a scaled Levenberg–Marquardt algorithm to the equation:




Figure 4.  Effects of 1 µM CPA on currents and related I–V relationships. (a–c) Sets of current traces obtained 
from a patch (a) before, (b) 1 min and (c) 4 min after solution change to K–H solution containing 1 µM CPA. 
(d) Peak currents plotted against voltage excursion to give I–V relationships here illustrating a ~ 38% alteration 
in maximum peak current following the solution change.
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Peak current densities (I, in pA/µm2) were thus related to clamped voltage excursion (V) through the maxi-
mum current (Imax, in pA/µm2), voltage excursion at half-maximum current (V50, in mV) and a steepness fac-
tor (k, in mV). As recordings were taken before and after solution change from a single patch in each case, the 
results were paired and thus analysed by paired Student’s t-tests. Values of the mean, SEM and p values for each 
parameter are compared in Table 1.
Solution changes in the control experiments introducing 0 µM CPA did not result in significant changes in 
Imax, V50 or k. Although statistical comparisons did not suggest significant changes in Imax between control (0 µM) 
and 0.1 µM CPA concentrations, 1 µM CPA produced noticeable, statistically significant ~ 30% increases in Imax. 
In contrast, both 0.1 µM and 1 µM CPA caused only small decreases (2–3 mV, < 1.0) in V50 and k, similar to 
those produced by the control experiments. These changes thus reflected the comparisons in Fig. 6 suggesting 
I–V relationships of similar form differing principally in their maximum currents.
Discussion
Possible feedback,  [Ca2+]i-mediated, in vitro, INa downregulation was first demonstrated in skeletal muscle cell 
lines and  Nav1.4-transfected cultured HEK293 cells following rapid photo-release and  Ca2+ overspill from neigh-
bouring  Ca2+ channels. This were abolished by mutations in the  Ca2+-binding-EF hands on CaM or the  Nav1.4 
C-terminal IQ domain implicating direct or indirect  Ca2+ binding to C-terminal functional groups in Nav1.4 
1–3,7,8. Subsequent experiments in intact loose patch clamped native murine muscle fibres correspondingly showed 
reduced or increased INa following respective activation or inhibition of SR  Ca2+ release by direct pharmaco-
logical, caffeine and 8-CPT-mediated, RyR1 activation, or dantrolene-mediated RyR1 inhibition. Dantrolene 
pretreatment additionally abrogated the INa downregulatory effects of both 8-CPT and  caffeine9,10.
The present studies further test and extend the resulting INa downregulation hypothesis. Previous fluo-3-AM 
and fura-PE3-AM  Ca2+ fluorescence studies in rat soleus and oesophageal striated muscle reported that in 
common with caffeine, cyclopiazonic acid (CPA)15,22 increases bulk cytosolic  Ca2+ concentrations,  [Ca2+]i13,14. 
However, CPA acts by inhibiting sarcoplasmic reticular (SR)  Ca2+-ATPase (SERCA)-mediated cytosolic  Ca2+ 
re-uptake15,22 rather than activating RyR-mediated SR  Ca2+ release. This additionally causes SR  Ca2+ store deple-
tion that itself can trigger store-operated  Ca2+ entry (SOCE) potentially further increasing  [Ca2+]i23. In common 
with the recent studies, experiments were performed on intact native skeletal myocytes. Use of the loose patch 
clamp technique avoided intracellular perturbations otherwise arising from conventional patch clamp access. 
Further introduction of novel solution change procedures permitted paired comparisons between families of INa 
elicited by progressively depolarizing test steps before and following applied solution changes within the same 
patch, without perturbing the patch seal. These matched comparisons avoided problems arising from previously 
Figure 5.  Effects of 0.5 mM caffeine challenge in the presence of 1 µM CPA. (a–c) Families of current traces 
from a patch (a) before, (b) 1 min and (c) 4 min after a preparation first pre-incubated with 1 µM CPA for 
13 min underwent a solution change to one containing 0.5 mM caffeine in addition to 1 µM CPA. (d) Peak 
currents plotted against voltage excursion to give I–V relationships.
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reported between-patch INa variabilities reflecting non-uniform membrane ion channel distributions in muscle 
 fibres16.
The INa recordings were unchanged by solution substitutions when these omitted CPA. However, in contrast 
to the previous observations in experiments using RyR1  activators9,10, substituting control for CPA-containing 
test solutions increased rather than decreased INa. Thus, CPA (1 µM) statistically significantly increased mean 
maximum currents (Imax) by ~ 31.4%. These effects were demonstrable from 1 min, and stably persisted in patches 
maintained for at least 4 min, following the solution change. The currents otherwise showed similar time courses, 
and similar steady-state half-maximum voltages, V0.5, and steepness factors, k.
These findings directly contrast with previously reported 81% decreases in Imax, accompanied by shifts in V0.5, 
through similar, 1–10 min intervals following 0.5 mM caffeine challenge, despite the common effects of caffeine 
and CPA in increasing bulk cytosolic  [Ca2+]i. Furthermore, whereas 0.5 mM caffeine had been reported to reduce 
INa when applied by  itself10, we additionally report that CPA pre-treatment abrogated this effect. This parallels 
previous reports that CPA pre-incubation abrogated the arrhythmogenic effects of caffeine in murine  hearts21. 
Both these effects of CPA thus more closely resembled that of dantrolene, despite its effects in decreasing rather 
than increasing  [Ca2+]i. Dantrolene applied alone had caused significant, 14.9%, increases in Imax10.
Figure 6.  Comparison of current–voltage relationships through experimental manoeuvres. Mean (± SEM) peak 
currents from all patches plotted against voltage excursion giving I–V relationships, comparing measurements 
before and 1 min after solution change to one containing (a,d) 0 µM, (b,e) 0.1 µM CPA and (c,f) 1 µM CPA. Left 
panels (a–c) show comparisons of mean values of the observed currents with error bars representing standard 
errors of the mean (SEM) obtained from between-patch, unpaired, comparisons. Right panels (d–f) show I–V 
relationships normalized to maximum peak currents for each individual patch prior to CPA challenge thereby 
correcting for between-patch variations in peak current, representing their means and SEMs. Numbers of 
different patches (n value) are indicated above each graph; each patch contributed two measurements at a given 
voltage as part of sequences imposing progressively increasing and decreasing voltage steps.
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The contrasting actions of RyR1 agonists and SERCA antagonists on INa implicate correspondingly contrast-
ing effects on the local  Ca2+ levels to which Nav1.4 is exposed, despite their similar reported effects on bulk 
cytosolic  [Ca2+]i13,14. Besides the surface sarcolemma, Nav1.4 occurs in the transverse (T-)  tubules17,18 themselves 
accounting for ~ 80% of total muscle  membrane19, thereby contributing substantial INa. T-tubular membranes 
come into close proximity to SR terminal cisternal membranes containing the RyR1-Ca2+ release channels, leav-
ing electron-microscopically demonstrable narrow, ~ 15 nm, T-SR gaps permitting the  Cav1.1-RyR1 interactions 
strategic to excitation–contraction  coupling24–26. Although ultimately continuous with remaining cytosol, T-SR 
gaps form restricted intracellular diffusion spaces close to the RyR1-Ca2+ release sites potentially generating 
microdomains with local  Ca2+ concentrations,  [Ca2+]TSR, distinct from the remaining bulk  [Ca2+]i, that might 
modulate T-tubular, even if not surface membrane  Nav1.4 function (Fig. 7).
Table 1.  Results of fits of two-state Boltzmann equation before and immediately after solution change. Three 
conditions shown, giving mean ± SEM values for between-patch maximum current, Imax (pA/µm2), half 
maximal voltage, V50 (mV) and steepness factor, k (mV). Significance of paired differences between results 
obtained before and 1 min following solution change expressed as the p value obtained from within-patch two-
tailed paired Student’s t test. *Denotes a significant difference where p < 0.05.
Condition Variable Before (mean ± SEM) 1 min (mean ± SEM) n value p value
Control
Imax − 14.86 ± 3.95 − 16.93 ± 5.24 5 0.2656
V50 52.09 ± 1.74 48.33 ± 2.60 5 0.1174
k 5.53 ± 0.41 5.15 ± 0.36 5 0.4471
0.1 µM CPA
Imax − 10.89 ± 2.46 − 12.82 ± 3.08 6 0.1375
V50 48.21 ± 2.35 45.01 ± 1.90 6 0.0445*
k 5.85 ± 0.65 4.90 ± 0.35 6 0.0476*
1 µM CPA
Imax − 21.74 ± 4.27 − 28.57 ± 5.67 6 0.0062*
V50 49.14 ± 1.66 47.16 ± 1.71 6 0.0002*
k 6.02 ± 0.39 5.30 ± 0.27 6 0.0476*
Figure 7.  T-SR  Ca2+ microdomain effects reconcile present with previous results. (A) In previous 
 experiments9,10, caffeine and 8-CPT-induced RyR1-Ca2+ release channel opening increased fluxes of SR store 
 Ca2+ into the T-SR space increasing its  Ca2+ concentration,  [Ca2+]TSR13, and ultimately (B) that of remaining 
cytosol,  [Ca2+]i. This inhibits INa. Such actions were antagonized by dantrolene.  [Ca2+]i is here also increased by 
(B) inhibiting cytosolic  Ca2+ re-uptake by the SERCA inhibitor  CPA14, but (C) the consequent depletion of SR 
 Ca2+, reduces SR store  Ca2+ fluxes into the T-SR space. The latter correspondingly reduces  [Ca2+]TSR relieving its 
background inhibition of, thereby increasing, INa.
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The paradoxically contrasting results produced by RyR1 agonists,  antagonists9,10, and SERCA inhibitors on 
INa may then reflect similarly contrasting changes in  [Ca2+]TSR. Direct caffeine or 8-CPT induced background 
SR RyR1-Ca2+ channel activation would increase  Ca2+ release into the T-SR gap increasing  [Ca2+]TSR thereby 
inhibiting T-tubular  Nav1.4, as well as ultimately increasing bulk cytosolic  [Ca2+]i, with dantrolene producing 
opposite or antagonistic  effects9,10. CPA-mediated inhibition of SERCA-mediated  Ca2+ uptake in the present 
experiments would similarly increase bulk cytosolic  [Ca2+]i but would deplete SR store  Ca2+. The latter would 
instead reduce RyR1-mediated  Ca2+ fluxes from SR lumen to T-SR space and diminish  [Ca2+]TSR. This would 
explain the contrasting effects of CPA in increasing T-tubular  Nav1.4 activity reported here. The depleted SR 
store  Ca2+ would also explain the observed CPA-mediated abrogation of the known inhibitory actions of caf-
feine on INa. Thus the SR  Ca2+ depletion would compromise  Ca2+ release into the T-SR gap through the activated 
RyR1-Ca2+ channels preventing any increase in  [Ca2+]TSR. The present experiments thus complement possible 
future attempts at direct fluorescent  Ca2+ indicator  [Ca2+]TSR measurements seeking such  Ca2+ microdomains. 
However, the latter could be significantly hindered if not precluded by the small dimensions and dispersed nature 
of the T-SR compartment. Nevertheless, future theoretical diffusional modelling studies could well explore the 
extent to which released SR  Ca2+ could accumulate within or become depleted from subcellular structures with 
architectures quantitatively matching those of T-SR junctions.
T-tubular as opposed to surface membrane  Nav1.4 function might then possess distinct features reflecting 
the specific T-tubular roles in excitation–contraction coupling as opposed to surface membrane action potential 
propagation. These could be important in both normal and clinical neurological disorders of muscle function. 
Elevated  [Ca2+]TSR following sustained activity or in some human skeletal  myopathies27 could inhibit tubular 
 Nav1.4 function. Mutations in the Nav1.4 C-terminal EF hand-like domain possibly disrupting  Ca2+-mediated 
inhibition of Nav1.4 function were recently implicated in a myotonic hyperexcitability  disorder28,29. Finally, 
structural triad junction changes might also affect excitation–contraction coupling processes extending to INa 
regulation by  Ca2+ signalling. For example, the T-SR gap is altered by normal physiological perturbations such 
as imposed  exercise30,31. A mutation in junctophilin (JP2), thought involved in triad junction formation and 
maintenance was associated with increased myotube diameters and resting  [Ca2+]i, and decreased RyR1-mediated 
 Ca2+ release and excitation–contraction coupling  gain32.
Materials and methods
All experiments were regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 
2012 following ethical review and approval by the University of Cambridge Animal Welfare and Ethical Review 
Body (AWERB). All procedures fell within the scope of Schedule 1 of the UK Animals (Scientific Procedures) 
Act (1986). The loose patches were made on single fibres within intact muscle preparations studied before and 
following challenge with extracellularly applied CPA directed at the intracellular SERCA  target15. This involved 
solution change protocols permitting within-patch comparisons in view of established between-patch variations 
in maximum  Na+  current16. This restricted experiments to each applying a single protocol to any one patch and 
studying one patch in a single fibre only within each dissected muscle.
Tissue preparation. C57BL6 wild type mice were killed by cervical dislocation (Schedule I, UK Animals 
(Scientific Procedures) Act 1986) by Home Office licensed personnel and immediately dissected. All exposed tis-
sues were bathed in Krebs–Henseleit (KH) extracellular solution (mM: 130 NaCl, 4.0 KCl, 1.2 HEPES, 1.0  MgCl2, 
1.8  CaCl2, 10 glucose and 2.0 Na-pyruvate; pH adjusted to 7.4 using 1 M NaOH) throughout. The skin was 
reflected to expose gastrocnemius muscle. The overlying biceps femoris muscle was dissected from its superficial 
surface. The Achilles tendon was ligatured, bisected distally, and gastrocnemius and soleus muscles reflected. 
Their proximal attachments were freed by bisecting the femur, tibia and fibula, and all other muscles ~ 2 mm 
above and below the knee joint. The resulting preparation was immediately immersed in KH solution.
Bath setup and solution exchanger. The dissected muscle was placed into the adapted bath containing 
KH solution and fixed to its Sylgard surface using two A1 insect pins. One was inserted through the proximal 
bony structures, and the thread attached distally was tied around the other, holding the muscle under slight 
tension. A bespoke-fitting 3D-printed bath obturator was inserted to reduce bath volume from ~ 30 to 4  ml 
and hold the necessary tubes and electrodes (Fig. 8a). This together with a solution exchanger permitted rapid, 
complete solution changes minimally disturbing the patch. This used KH solution containing cyclopiazonic acid 
(CPA; Sigma-Aldrich, UK) introduced from a 10 mM stock in DMSO or containing vehicle alone. It employed 
two reciprocally connected syringes such that injection of a solution into the bath by one withdrew solution at 
the same rate by the other keeping bath fluid levels constant (Fig. 8b). The made-up solutions had been stored 
in small containers equilibrated for > 1 h prior to experimentation to a 20 °C temperature monitored by thermo-
couple. The 50 ml syringe capacities, far exceeding the obturated bath volume, ensured complete exchange in a 
process taking < 60 s. Their tubes were inserted into the bath obturator (Fig. 8a) as were the bath active ground 
current injection electrode (a stainless-steel wire) and the bath ground-sensing electrode (an ensheathed Ag/
AgCl electrode containing KH solution) which actively maintained the bath at ground potential.
Loose patch pipette manufacture and deployment. Borosilicate glass capillary tubes (GC150-10; 
Harvard Apparatus, Cambridge, UK) were pulled by a Flaming/Brown micropipette puller (Model P-97 Sutter 
Instrument Co., Novato, CA) using a 5-step program to achieve a progressive taper. The tips were visualized 
under a microscope with a calibrated eyepiece graticule at 250× magnification and scored using a diamond 
knife mounted perpendicularly to its long axis at a position giving a 30 µm internal diameter. A transverse force 
applied distal to this site produced a clean perpendicular fracture. The tips were fire-polished using an electri-
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cally heated nichrome wire under 400× magnification. The pipettes were bent through 45° at 1 mm from the 
tip, by heating with a nichrome filament and a transverse displacing force. Internal tip diameters were measured 
under 1000× magnification. Pipettes with 20–30 µm diameters were selected for use. A recording pipette was 
inserted into a pipette holder with a chloridized silver wire. This was connected to the headstage of the loose 
patch amplifier and held at 45° such that the pipette tip contacted the muscle surface perpendicularly (Fig. 8b). 
KH solution was drawn up from the bath using the suction syringe to provide electrical continuity through an 
Ag/AgCl electrode.
Loose patch clamp recording. The custom-built loose patch amplifier circuit compensated for voltage 
drops across the pipette resistance in series with the patch and the current flow through the relatively low seal 
resistance of the loose patch configuration (typically < 2 MΩ compared to many GΩ in tight patch). Its variable 
resistances were adjusted to match the voltage drop across the pipette and seal resistances so that the mem-
brane patch was clamped to the command potential and the circuit output corresponded to the current flowing 
through the patch only (Fig. 8c). Voltage clamp steps were delivered using an IBM-compatible computer. As the 
pipette tip being clamped was extracellular to the patch, the applied voltage steps produced membrane potential 
excursions of opposite sign to the conventionally expressed membrane potential. They took place relative to the 
resting membrane potential (RMP); they are accordingly referred to as such in this report.
The pulse protocols each began with a hyperpolarizing pre-pulse of − 40 mV relative to the resting membrane 
potential (RMP) to relieve any residual  Nav1.4 inactivation at the RMP. This was then followed by a variable 
test pulse starting at (RMP − 40) mV and altered in + 10 mV increments with each successive cycle until a test 
voltage of (RMP + 120) mV was reached (Fig. 8d). The series of voltage steps was then repeated, but with the test 
voltage steps taking the opposite order running from (RMP + 120) to (RMP − 40) mV with 10 mV decrements.
Comparison of currents from these two sequences made it possible to check for stability of patch clamp 
current characteristics. A full set of pulses thus consisted of 34 cycles of such voltage steps, each of which were 
delivered at 2 s intervals. These permitted a derivation of current–voltage curves reflecting channel activation, an 
experimental approach that had been independently corroborated in inactivation protocols in previous studies 
employing the loose patch clamp  technique9,10. Residual leak was corrected for by the P/4 protocol, whereby four 
voltage steps of opposite sign and a quarter in magnitude to the test pulse were delivered immediately after it. 
The control P/4 pulses traversed voltages that would not activate any voltage-gated conductances giving currents 
that represented leak currents for removal by summation with the test pulse record.
With the pipette tip immersed in the bath solution, the bath clamping was adjusted for offset so that the 
pipette electrode recorded zero voltage. The pipette resistance was compensated through its corresponding vari-
able resistance, under guidance from an imposed square wave voltage clamp waveform viewed on an oscilloscope. 
The pipette tip was positioned over the centre of the convex surface of the gastrocnemius muscle, and slowly 
lowered using the fine vertical micromanipulator control under dissection microscope viewing. After achieving 
substantial cell surface contact producing a change in resistance at the pipette tip indicated by a deflection in 
the oscilloscope trace, gentle suction was applied, and the seal resistance compensated. A 15 ms depolarizing 
step of + 100 mV relative to RMP was applied to test patch viability. If the resulting current recording did not 
show a clear-cut  Na+ current of suitable shape or magnitude, the patching procedure was re-attempted at an 
adjacent site. Viable patches were tested over a range of clamped voltage steps (Fig. 8d) to obtain a family of 
current responses. The solution change was carried out by sliding the connected plungers fully across in one 
continuous motion whilst observing the square wave on the oscilloscope. Small changes (< 5%) in seal resistance 
required readjustment of the corresponding resistance to cancel; large changes signalled disruption of the patch. 
The voltage clamp step protocol was then repeated at 1 min, 4 min and 8–10 min after the solution change, for 
as long as patch seal resistance permitted.
Statistical analysis. The currents derived from the pulse protocol applied to each patch were normal-
ized to the estimated patch area calculated using the loose patch pipette diameter to give current densities, and 
expressed as means ± SEM. Following Shapiro-Wilkes tests for normality, values of currents, I (pA/µm2), half 
maximal voltage, V50 (mV) and steepness factor, k (mV) were subject to within-patch paired t-test comparisons 
of values before and following CPA challenge.
Figure 8.  Experimental configuration. (a) Top view of bath setup for loose patch clamp. Scheme showing 
the bath obturator insert with pinned muscle preparation. Holes allow insertion of the bath sense and ground 
electrodes, used to actively clamp the bath potential, and tubes for solution exchange. They are continuous 
with the bath through cut-outs below the surface, demarcated by the dashed lines. (b) Side view of loose patch 
clamp setup showing micromanipulator-mounted headstage with recording pipette, holder, suction syringe and 
solution exchanger. (c) Equivalent circuit for loose patch clamp electrode on muscle membrane. The solution 
in the pipette, of resistance Rpip, is clamped at pipette voltage, Vpip. The voltage error arising from current flow 
through the patch, represented by patch resistance Rpatch and the cell membrane resistance Rcell, along with the 
pipette resistance (Rpip) is corrected by bridge circuit in the loose patch clamp  amplifier9,10. The cell is at its 
resting membrane potential, RMP, represented by the resting voltage Vrest during establishment of the patch. (d) 
Voltage clamp step protocol consisting of hyperpolarizing pre-pulse to (RMP − 40) mV followed by a variable 
test pulse starting at − 40 mV altered in 10 mV increments with successive pulse cycles to a test voltage of 
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Study limitations. The present explorations thus developed a novel experimental configuration and simul-
taneously applied this to demonstrate for the first time within-patch alterations in Nav1.4 properties following 
hitherto untested pharmacological manipulations of  [Ca2+]i. Its validation involved added confirmatory test step 
sequences to confirm recording stability. The added cycles of voltage steps potentially limited the testable range 
of applied pulse protocols owing to alterations in seal resistances with time following patch establishment. The 
latter were noticeable at later, 4 min, times at the higher CPA concentrations. However, these did not preclude 
acquisitions of INa activation curves sufficient for full quantification and comparisons of current–voltage rela-
tionships before and following CPA challenge.
Ethical approval. This study was carried out in compliance with the ARRIVE guidelines. This research has 
been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following 
ethical review and approval by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB). 
All procedures were completed by Home Office-licensed personnel and fell within the scope of Schedule 1 of the 
UK Animals (Scientific Procedures) Act (1986).
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable 
request.
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